Motivational Interviewing Applied to Individuals With Diabetes
The Effect of Motivational Interviewing on Well-being, Stress and Difficulties in Individuals With Diabetes
Bozok University
66 participants
Oct 15, 2024
INTERVENTIONAL
Conditions
Summary
This study will be conducted using a randomized controlled trial design to evaluate the effect of online individual motivational interviewing on well-being, stress and difficulties in individuals with diabetes. The study will be conducted between March 2024 and March 2025 with individuals with Type 2 Diabetes who are followed up in Yozgat Bozok University Health Practice and Research Center Internal Medicine Polyclinic. The motivational interview group will receive a motivational interview once a week, lasting a maximum of 40 minutes, consisting of a total of four sessions. Chi-square (X2), t-test, repeated measures analysis of variance, Pearson correlation coefficient, partial eta-square and linear regression analysis will be used to evaluate the data.
Eligibility
Inclusion Criteria3
- volunteering to participate in the study,
- Having a diagnosis of Type 2 Diabetes,
- HbA1C values outside the normal range for the last 2-3 months.
Exclusion Criteria2
- Having a diagnosis of Type 1 Diabetes,
- Having limitations in reading and understanding Turkish.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Motivational interviewing will be conducted in four sessions and the session duration will be maximum 40 minutes. The session will be conducted individually and online once a week. For the individual interview, the appropriate day and time will be determined with the individuals with diabetes and the researcher before the first session and the sessions will continue on the same day and time every week. The researcher will remind the participant about the time of the session by calling the participant by phone one day before each session. Motivational interview sessions will be held online on the Whatsapp platform.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06345196